Ir al contenido
Company overview
Team
What we offer
Facilities
Publication track
News
Contact
Menú
Company overview
Team
What we offer
Facilities
Publication track
News
Contact
Publication track
Nat Med
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
2023 Mar
Nat Commun
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
2023 Sep 20
Sci Adv
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.
2022 Jan 21
Blood Cancer Discov
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
2024 May 1
Blood
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
2022 Jan 20
Blood
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
2021 Jan 7
Preview
Página
1
Página
2
Página
3
Next
Modeling Science for Cancer Therapy
Contact us